NCT04739670 2024-03-01
BELLA
Peter MacCallum Cancer Centre, Australia
Phase 2 Unknown
Peter MacCallum Cancer Centre, Australia
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Swedish Medical Center
All India Institute of Medical Sciences
WiSP Wissenschaftlicher Service Pharma GmbH
Myrexis Inc.